Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-004001-26Phase 3Completed
Phase 3, randomised, open-label trial in hip fracture comparing Bupivacaine fascia iliaca compartment block with Intravenous morphine sulphate (2 arms). Primary endpoint: Change in maximum tolerable passive hip flexion. Started Feb 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-004001-26.